Delivery Order SPE2DB22D3501-SPE2DB26FTE41
- Not listed
- The Defense Logistics Agency awarded a $2,148.62 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). The contract employs firm fixed-price pricing with no set-aside designation, indicating a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,535.99 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.49 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 26, 2025, with completion targeted for September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,303.56 to AmerisourceBergen Drug Corp for Ambien CR 6.25 mg tablets (100-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,076.82 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). The contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a competitively awarded, non-set-aside transaction with firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,751.15 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,829.57 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,606.82 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. The contract employs firm fixed pricing and is not set aside, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,167.17 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a firm fixed price and an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract was issued on September 8, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTE41Delivery Order
The Defense Logistics Agency awarded a $2,208.72 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 22, 2025, and performance will be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical umbrella contract, the company supplies a comprehensive range of pharmaceuticals and medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This award for Ambien CR tablets reflects the contractor's ongoing role in fulfilling routine pharmaceutical supply requirements through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/21/25 |